Loading clinical trials...
Loading clinical trials...
The purpose of the study is to determine whether a p38 kinase inhibitor reduces inflammation in atherosclerotic plaque
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Bristol-Myers Squibb
NCT07547098 · Cardiovascular Diseases (CVD), Chronic Kidney Disease, and more
NCT07185022 · Stroke, Cerebrovascular Disorders, and more
NCT07491315 · Fatigue Syndrome, Chronic, Cardiovascular Diseases
NCT07487363 · Atherosclerotic Cardiovascular Diseases, Endothelial Dysfunction
NCT07256249 · Cardiovascular Diseases
Southeast Clinical Research, Llc
Chiefland, Florida
Jacksonville Center For Clinical Research - Univ Campus
Jacksonville, Florida
Florida Cardiovascular Institute
Tampa, Florida
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions